Real-life efficacy of osimertinib in pretreated patients with advanced nonsmall cell lung cancer harboring EGFR T790M mutation.
Auteurs : Auliac JB, Perol M, Planchard D, Monnet I, Wislez M, Doubre H, Guisier F, Pichon E, Greillier L, Mastroianni B, Decroisette C, Schott R, Le Moulec S, Arrondeau J, Cortot AB, Geriniere L, Renault A, Daniel C, Falchero L, Chouaid C.
